WO2023053015 - BICYCLIC AMINE DERIVATIVES AS GABAA α5 RECEPTOR MODULATORS

National phase entry is expected:
Publication Number WO/2023/053015
Publication Date 06.04.2023
International Application No. PCT/IB2022/059214
International Filing Date 28.09.2022
Title **
[English] BICYCLIC AMINE DERIVATIVES AS GABAA α5 RECEPTOR MODULATORS
[French] DÉRIVÉS BICYCLIQUES D'AMINE SERVANT DE MODULATEURS DU RÉCEPTEUR GABAA α5
Applicants **
RICHTER GEDEON NYRT.
Inventors
SZABÓ, György
POTOR, Attila
ERDÉLYI, Péter
BATA, Imre
TÚRÓS, György István
KAPUS, Gábor László
ÉLIÁS, Olivér
Priority Data
P2100338   29.09.2021   HU
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting3709
EPO Filing, Examination, Granting37777
Japan Filing, Examination, Granting3478
South Korea Filing, Examination, Granting4773
USA Filing, Examination, Granting39340
MasterCard Visa
Total: 89,077

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] α5 receptor, process for the preparation and intermediates of the preparation process thereof, pharmaceutical compositions comprising them alone or in combination with one or more other active ingredients and their use as medicaments.[French] α5, un procédé pour leur préparation et des intermédiaires pour le procédé de préparation de ceux-ci, des compositions pharmaceutiques les comprenant seuls ou en combinaison avec un ou plusieurs autres principes actifs et leur utilisation en tant que médicaments.

Rejoining the server...